177lu-psma-617
novartis
['177lu,psma,617', '#vision', 'crpc', 'psma-617 ', 'vision trial']
tumor dosimetry of 177lu-psma-617 for the treatment of #mcrpc: results from the #vision trial sub-study. presentation by bernd krause . #asco23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology